Summary:
Pearland Neurology Services is conducting a clinical trial to evaluate the treatment satisfaction with erenumab in adult patients with migraines.
Qualified Participants Must:
- Be at least 18 years old
- Have a history of migraines with or without aura for at least 1 year
- Be currently on migraine preventive medication but don't have relief
- Be willing to participate in 5 outpatient visits and 4 phone check-ins over a 28-32 week period.
Qualified Participants May Receive:
Eligible participants will receive up to $75 per visit and will be compensated following the completion of each clinic study visit.